These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
209 related items for PubMed ID: 7817828
21. Urinary cross-linked N-telopeptides of type I collagen and bone metabolic diseases. Xue Y, Jia W, Zhang H, Dong J, Clemens JD, Tian X. Chin Med J (Engl); 1999 Feb; 112(2):149-52. PubMed ID: 11593583 [Abstract] [Full Text] [Related]
22. Urinary gamma-glutamyltransferase (GGT) as a potential marker of bone resorption. Asaba Y, Hiramatsu K, Matsui Y, Harada A, Nimura Y, Katagiri N, Kobayashi T, Takewaka T, Ito M, Niida S, Ikeda K. Bone; 2006 Dec; 39(6):1276-82. PubMed ID: 16942925 [Abstract] [Full Text] [Related]
23. Evaluation of an immunoassay method for the determination of urinary collagen crosslink excretion. Hata K, Miura M. Ann Clin Biochem; 1994 Jul; 31 ( Pt 4)():374-5. PubMed ID: 7979105 [No Abstract] [Full Text] [Related]
24. Bone resorption in multiple myeloma and in monoclonal gammopathy of undetermined significance: quantification by urinary pyridinium cross-links of collagen. Pecherstorfer M, Seibel MJ, Woitge HW, Horn E, Schuster J, Neuda J, Sagaster P, Köhn H, Bayer P, Thiébaud D, Ludwig H. Blood; 1997 Nov 01; 90(9):3743-50. PubMed ID: 9345061 [Abstract] [Full Text] [Related]
25. Urinary excretion of collagen degradation markers by sows during postpartum uterine involution. Belstra BA, Flowers WL, Croom WJ, Degroot J, See MT. Anim Reprod Sci; 2005 Jan 01; 85(1-2):131-45. PubMed ID: 15556316 [Abstract] [Full Text] [Related]
26. Simultaneous free and glycosylated pyridinium crosslink determination in urine: validation of an HPLC-fluorescence method using a deoxypyridinoline homologue as internal standard. Monticelli E, Aman CS, Costa ML, Rota P, Bogdan D, Allevi P, Cighetti G. J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Sep 15; 879(26):2764-71. PubMed ID: 21855424 [Abstract] [Full Text] [Related]
27. Method for the isolation and purification of pyridinoline and deoxypyridinoline crosslinks from bone by liquid chromatographic techniques. Meddah B, Kamel S, Giroud C, Brazier M. Prep Biochem Biotechnol; 1999 Feb 15; 29(1):63-75. PubMed ID: 10069434 [Abstract] [Full Text] [Related]
28. Markers of bone resorption--measurement in serum, plasma or urine? Huber F, Traber L, Roth HJ, Heckel V, Schmidt-Gayk H. Clin Lab; 2003 Feb 15; 49(5-6):203-7. PubMed ID: 15285175 [Abstract] [Full Text] [Related]
29. Markers of bone resorption predict hip fracture in elderly women: the EPIDOS Prospective Study. Garnero P, Hausherr E, Chapuy MC, Marcelli C, Grandjean H, Muller C, Cormier C, Bréart G, Meunier PJ, Delmas PD. J Bone Miner Res; 1996 Oct 15; 11(10):1531-8. PubMed ID: 8889854 [Abstract] [Full Text] [Related]
30. Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis. Delmas PD, Schlemmer A, Gineyts E, Riis B, Christiansen C. J Bone Miner Res; 1991 Jun 15; 6(6):639-44. PubMed ID: 1887826 [Abstract] [Full Text] [Related]
31. Urinary markers of type I collagen degradation in the dog. Allen MJ, Allen LC, Hoffmann WE, Richardson DC, Breur GJ. Res Vet Sci; 2000 Oct 15; 69(2):123-7. PubMed ID: 11020362 [Abstract] [Full Text] [Related]
32. Quantitation of biochemical markers of bone resorption following strontium-89-chloride therapy for metastatic prostatic carcinoma. Papatheofanis FJ. J Nucl Med; 1997 Aug 15; 38(8):1175-9. PubMed ID: 9255144 [Abstract] [Full Text] [Related]
33. Urinary excretion of pyridinium crosslinks of collagen in patients with osteoporosis and the effects of bone fracture. McLaren AM, Hordon LD, Bird HA, Robins SP. Ann Rheum Dis; 1992 May 15; 51(5):648-51. PubMed ID: 1616331 [Abstract] [Full Text] [Related]
34. Factors modifying collagen catabolism in patients with ankylosing spondylitis. Müller A, Bölzner C, Eidner T, Smolenski UC, Hein GE. Eur J Med Res; 2007 Nov 05; 12(11):568-72. PubMed ID: 18024266 [Abstract] [Full Text] [Related]
35. Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease. Garnero P, Gineyts E, Riou JP, Delmas PD. J Clin Endocrinol Metab; 1994 Sep 05; 79(3):780-5. PubMed ID: 8077361 [Abstract] [Full Text] [Related]
36. Pyridinium crosslinks as markers of bone resorption in patients with breast cancer. Paterson CR, Robins SP, Horobin JM, Preece PE, Cuschieri A. Br J Cancer; 1991 Nov 05; 64(5):884-6. PubMed ID: 1931610 [Abstract] [Full Text] [Related]
37. Longitudinal study of urinary hydroxy-pyridinium cross-links and growth in healthy infants: higher values with breastfeeding and after daytime sleep. Lutchman EC, Hardwick TA, Biener R, Chowdhury HA, Trout JR, Shapses SA. Exp Clin Endocrinol Diabetes; 1998 Nov 05; 106(1):51-6. PubMed ID: 9516060 [Abstract] [Full Text] [Related]
38. Urinary excretion level of hydroxylysylpyridinoline as an index of bone resorption. Yoshihara K, Nemoto S, Nagata M. Biol Pharm Bull; 1994 Jun 05; 17(6):840-2. PubMed ID: 7951150 [Abstract] [Full Text] [Related]
39. Circadian variation of urinary type I collagen crosslinked C-telopeptide and free and peptide-bound forms of pyridinium crosslinks. Aoshima H, Kushida K, Takahashi M, Ohishi T, Hoshino H, Suzuki M, Inoue T. Bone; 1998 Jan 05; 22(1):73-8. PubMed ID: 9437516 [Abstract] [Full Text] [Related]
40. Evaluation of urinary hydroxypyridinium crosslink measurements as resorption markers in metabolic bone diseases. Robins SP, Black D, Paterson CR, Reid DM, Duncan A, Seibel MJ. Eur J Clin Invest; 1991 Jun 05; 21(3):310-5. PubMed ID: 1909635 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]